White House reportedly turned down additional Pfizer vaccine purchase over the summer
The U.S. doesn't have enough COVID-19 vaccine doses to go around — but it reportedly could've had 100 million more.
This summer, countries began reserving millions of doses of coronavirus vaccine candidates. Pfizer's vaccine has proven one of the most viable of that lot, and the Department of Health and Human Service purchased 100 million doses of the two-shot vaccine back in July. But HHS could have doubled that supply and decided against it, people familiar with the matter tell The New York Times.
After HHS' initial purchase of the Pfizer/BioNTech vaccine, Pfizer approached American officials again later in the summer to offer up another 100 million doses, per the Times. U.S. officials reportedly turned them down, leaving Pfizer to sell its doses to other countries. Now, it may not be able to offer any additional doses to the U.S. until June, the Times reports. That means the U.S. has only reserved enough of the Pfizer vaccine to vaccinate 50 million Americans. And that will likely be down to just 25 million by the end of the year, as Pfizer said last week it would only be able to deliver half of its promised doses this month.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
One possible explanation for the rejection is that the White House thought it would have enough doses if every developer had delivered an effective vaccine; Project Warp Speed does have purchase agreements with five other coronavirus vaccine developers. But beyond the 100 million doses it purchased from Moderna, most of those other candidates just aren't viable yet. It's possible that the Oxford/AstraZeneca vaccine, of which the U.S. reserved 400 million doses, will pull through, but it has so far proven less effective than Pfizer and Moderna's candidates.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
'A speaker courageous enough to stand up to the extremists in his own party'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
How could the Supreme Court's Fischer v. US case impact the other Jan 6. trials including Trump's?
Today's Big Question A former Pennsylvania cop might hold the key to a major upheaval in how the courts treat the Capitol riot — and its alleged instigator
By Rafi Schwartz, The Week US Published
-
Today's political cartoons - April 18, 2024
Cartoons Thursday's cartoons - impeachment Peanuts, record-breaking temperatures, and more
By The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published